1. Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors.
- Author
-
Zheng LY, Zhang NY, Zheng H, Wang KM, Zhang J, Meng N, and Jiang CS
- Subjects
- Humans, Animals, Mice, Structure-Activity Relationship, Molecular Structure, Human Umbilical Vein Endothelial Cells drug effects, Dose-Response Relationship, Drug, Ferroptosis drug effects, Phenylenediamines pharmacology, Phenylenediamines chemistry, Phenylenediamines chemical synthesis, Cyclohexylamines pharmacology, Cyclohexylamines chemical synthesis, Cyclohexylamines chemistry
- Abstract
Ferroptosis, a distinct type of cell death caused by iron and lipid peroxidation, has been associated with several diseases, including cardiovascular disorders. Ferrostatin-1 (Fer-1) is a known ferroptosis inhibitor, but its clinical application is limited by low efficacy and stability. In the present study, a series of Fer-1-based diamide derivatives was synthesized and evaluated to enhance ferroptosis inhibition and in vitro metabolic stability. The synthesized compounds were tested for their protective effects against Erastin-induced injury in human vascular endothelial cells (HUVECs). Among the derivatives, compound 36 exhibited the most potent anti-ferroptosis activity with an EC
50 value of 0.58 ± 0.02 µM. Remarkably, compound 36 also demonstrated superior stability in both microsomal (human and mouse) and mouse plasma assays. These findings indicated ferroptosis inhibitor 36 as a promising hit for further developing potential therapeutic drug candidates in cardiovascular diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF